An estimated 1.1 million people in the U.S. are currently living with HIV.That means the work to remove barriers to health ...

As the first COVID-19 vaccines are rolled out around the world, HIV/AIDS experts and advocates have sought to reassure those ...

Gilead Sciences recently announced that its Phase 3 ARTISTRY-1 trial met the primary endpoint for a novel single-tablet HIV ...

Gilead has become a significant name in the HIV landscape after its twice-yearly PrEP treatment Yeztugo touted 99.9% efficacy ...

The PP3 study highlights a disconnect between patients with HIV and healthcare providers, affecting ART adherence and satisfaction. Despite 80% of participants trusting their providers, 47.5% feel ...

People living with HIV are at an increased risk for lung cancer, with some studies estimating risk to be 1.5 to 3-fold higher compared with the general population. The exact reasons for this increased ...

Review of current evidence indicates immune checkpoint inhibitors offer comparable efficacy and safety for NSCLC in people ...

Despite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human ...

A nationwide campaign in Spain is raising awareness of the labour rights of people living with HIV, while strengthening the commitment of businesses, public administrations and civil society to combat ...

Limako currently serves as a board member at EK FM, where she utilises radio to promote disability awareness and inclusion. She is also the disability coordinator for Positive Convention, promoting ...

"You know, it's not the best news. But there was other news that could have been a lot worse, you know?" Charlie Sheen said.

ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to ...